Technology have transformed urine analysis in pregnancy. The responsibility for urine testing in antenatal care remains with health care provider. Monitoring have been self-testing for both blood and urine in diseases like diabetes. The changing child birth and NICE guideline advocated involvement of pts in antenatal care, which can improved by transferring of knowledge and skills. This survey is to evaluate opinions about pt self-testing and monitoring of urine during pregnancy in a UK district Hospital community. Methods: Questionnaire designed to evaluate pt and non-pt opinions of urine self-testing during pregnancy. Opinion evaluated were 67.6% pts & 32.4% others for:
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-Accepted practice involving self-monitoring e.g. Urine HCG -Knowledge of urine self-testing in pregnancy -Acceptance, skill transfer and investment in self-testing of urine during pregnancy Results: Home urine HCG testing; 79.8% support and 96.2% found HCG kits acceptable >90 % of pts used HCG self -testing. % Objectives: The aim of the study was to investigate the obstetric outcome of the women carriers of mitochondrial oxidative phosphorylation (OXPHOS) disorders mutation and to identify the frequent pregnancy complications. Methods: A retrospective review of obstetric history of women referred to our tertiary centre for prenatal screening of a mitochondrial disorder was carried out. All medical records were retrieved. Patients were divided into three groups: 1) women carrying heteroplasmic mitochondrial DNA (mtDNA) mutations 2) healthy women with a family history of mtDNA-related OXPHOS disorder, but no maternal mutation, 3) healthy women carrying heterozygote nuclear DNA (nDNA) mutations. Obstetric history and pregnancy complications were evaluated separately in the three groups and compared to the control group. Results: Seventy-five women were included: they had 287 cumulative pregnancies. There was no difference in obstetrical outcome of women in group 2, compared to the control group. Groups 1 and 3 had a significantly greater proportion of termination of pregnancy (TOP, 20% and 13% vs 0.8%, p<0.001) and less percentage of live births (51% and 69% vs 87%, p=0.001) compared to controls. Apart from this, the rate of obstetric complications in group 3 did not differ significantly from the control group. Conversely, obstetric history of women in group 1 was marked by a significantly greater rate of early miscarriages (26% vs 11% p=0.004), gestational diabetes (13% vs 3%, p=0.02), intra-uterine growth retardation (IUGR, 10% vs 1%, p=0.008), and postpartum hemorrhage than in controls (12% vs 2%, p=0.01). Objectives: To quantify actograph output in healthy third trimester pregnancies and investigate this in relation to computerised cardiotocograph (CTG). Methods: 42 women between 24 to 34 weeks of gestation underwent an ultrasound growth scan followed by a computerised CTG. Post capture analysis of the actograph recording was performed and expressed as a percentage of activity over time.
The actograph output results were analysed in relation to short term variation (STV) and fetal accelerations.
Results: There was no significant association of actograph output recording with STV (R =0.211; p = 0.178). However, accelerations >10bpm correlate significantly with actograph activity (R=0.387, p=0.015). Conclusions: Fetal movements assessed by the actograph are not associated with STV. As reduced STV is predictive of fetal acidosis, the lack of association was anticipated in healthy fetuses. However, we note that our data is limited by the fact that all traces were of a relatively short duration. We report that accelerations >10bpm were associated with actograph in our study. This suggests that actograph may be a reliable marker of movement quantification.
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Obstetric ultrasound of patients in prison. Objectives: We aimed to assess the prevalence of congenital CMV infection at birth and differentiate between maternal primary and non-primary infection within the same population. Methods: 11,715 consecutive newborns were screened for cCMV by PCR in saliva. Prevalence, type of maternal infection, socio-demographic, obstetrical and serological data were analysed. Results: Positive predictive value of CMV PCR in saliva was 59%, false positive results were associated with lower viral loads (p<0.001). Maternal seroprevalence was 61%, birth prevalence was 0.37%, resulting from primary and non-primary infections in 52% and 47.7% of cases respectively. The risk to deliver an infected baby after primary infection was increased in younger (OD=7.9), parous (OD=4.1) women born in high resources countries (OD=5.2) and from higher income groups (p=0.019). The only 2 risk factors to deliver an infected baby after non-primary infection were to be young (OD=4.6) and unemployed (OD=5.8). The risk to deliver an infected baby was 4-fold higher in women seronegative before their pregnancy (p=0.021). Conclusions: A positive CMV PCR in newborns' saliva should always be confirmed in a repeat-sample. Socio-demographic characteristics of women giving birth to an infected baby after primary and non-primary infection are different. Seronegative, parous women represent the highest risk population for cCMV in countries with low to intermediate seroprevalence. Urgent action is needed to stop the cCMV epidemic, particularly in this population easily identifiable by maternal serology and amenable to prevention messages. Ultrasound assessment of women at risk for non-primary infection in pregnancy is the only screening tool since serology is not contributive. Multivariate logistic regression analysis showed that cervical length (adjusted odds ratio(aOR) 5.85; 95% confidence interval (CI) 2.696-12.695; P≤0.0001) at 35∼36weeks and birthweight (aOR 1.003(95% CI 1.001-1.004, p<0.0001)were predictors for the onset of labour before 39 weeks of gestation. The area under the receiver-operating characteristics curve for the prediction of early onset of labour was 0.847 (95% CI 0.738-0.950) for cervical length and birthweight as test variable. Conclusions: Cervical length at 35-36 weeks of gestation and birthweights provides information about the likelihood of onset of labour before 39 weeks of gestations in women with history of previous CS and may be useful in individualising the gestational age for elective CS.
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The association between elastogram of the cervix and preterm delivery among parturients at risk for preterm delivery: a prospective study R. Boldes, O. Reichman, H. Sela, F. Lafi Obstetrics and Gynecology, Shaare Zedek Medical Centre, Mevassert Zion, Israel 
